# Tumor Exosome Liquid Biopsy Strategy to Diagnose Pancreatic Cancer

> **NCT06108531** · — · ENROLLING_BY_INVITATION · sponsor: **Shanghai Jiao Tong University School of Medicine** · enrollment: 400 (estimated)

## Conditions studied

- Pancreatic

## Interventions

- **OTHER:** 

## Key facts

- **NCT ID:** NCT06108531
- **Lead sponsor:** Shanghai Jiao Tong University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2023-11-01
- **Primary completion:** 2025-08-01
- **Final completion:** 2026-08-01
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2023-10-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06108531

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06108531, "Tumor Exosome Liquid Biopsy Strategy to Diagnose Pancreatic Cancer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06108531. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*